1.
Charrois-Durand C, Saad F, Barkati M, Lattouf J-B, Perrotte P, Karakiewicz PI, et al. A single-center, multidisciplinary experience with radium-223 dichloride in men with metastatic castrate-resistant prostate cancer. CUAJ [Internet]. 2022 Jan. 27 [cited 2026 May 22];16(6):199-205. Available from: https://cuaj.ca/index.php/journal/article/view/7591